Clinical and Genetic Analyzes of Age-related Macular Degeneration

Centre Hospitalier Intercommunal Creteil5 sites in 1 country6,000 target enrollmentNovember 2005

ConditionsMacular Degeneration

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Macular Degeneration
Sponsor: Centre Hospitalier Intercommunal Creteil
Enrollment: 6000
Locations: 5
Primary Endpoint: Genotypic factors
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this collection is to search for susceptibility genes for age-related macular degeneration (AMD) alone or in combination with environmental factors and to look for genes that modulate the AMD phenotype (particularly the response to treatment).

Registry

clinicaltrials.gov

Start Date

November 2005

End Date

November 2024

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Centre Hospitalier Intercommunal Creteil

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Age\> 55 years
•Diagnosis of exudative or atrophic AMD in at least one eye
•Patient informed of the objectives of the study and having freely signed the informed consent letter
•Patient affiliated to a social security scheme

Exclusion Criteria

•Other retinal or choroidal lesion in the studied eye
•History of severe systemic disease that could potentially hinder patient adherence to the study protocol: mental disorder, cancer, recent stroke or heart failure less than 3 months old.
•Known allergy to fluorescein, indocyanine green, iodine or ranibizumab